Associated Papers
Functional characterization of variants in human ABCC11, an axillary osmidrosis risk factor.
Toyoda Y et al.
Human Cell, 2024
APF2: an improved ensemble method for pharmacogenomic variant effect prediction.
Zhou Y et al.
The Pharmacogenomics Journal, 2024
38802404 (PubMed )
Supplement: 41397_2024_338_MOESM2_ESM.xlsx › Sheet1
Expanding the prostate cancer cell line repertoire with ACRJ-PC28, an AR-negative neuroendocrine cell line derived from an African-Caribbean patient.
Valentine H et al.
Cancer Research Communications, 2022
36643868 (PubMed )
Supplement: crc-22-0245-s07.xlsx › Variants_All_Exonic.exclude_ncR
An optimized prediction framework to assess the functional impact of pharmacogenetic variants.
Zhou Y et al.
The Pharmacogenomics Journal, 2019
30206299 (PubMed )
Supplement: 41397_2018_44_MOESM5_ESM.xlsx › Sheet1
ATP-Binding Cassette Transporters in the Clinical Implementation of Pharmacogenetics.
López-Fernández LA
Journal of Personalized Medicine, 2018
30563187 (PubMed )
Supplement: jpm-08-00040-s001.xlsx › Hoja1
Architecture of polymorphisms in the human genome reveals functionally important and positively selected variants in immune response and drug transporter genes.
Jin Y et al.
Human Genomics, 2018
Thin and thick primary cutaneous melanomas reveal distinct patterns of somatic copy number alterations.
Montagnani V et al.
Oncotarget, 2016
27095580 (PubMed )
Supplement: oncotarget-07-30365-s002.pdf
Functional characterization of common protein variants in the efflux transporter ABCC11 and identification of T546M as functionally damaging variant.
Arlanov R et al.
The Pharmacogenomics Journal, 2016
Earwax, osmidrosis, and breast cancer: why does one SNP (538G>A) in the human ABC transporter ABCC11 gene determine earwax type?
Toyoda Y et al.
Faseb Journal : Official Publication of the Federation of American Societies for Experimental Biology, 2009
Select a paper to view details